Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.



PFE_121905.jpg

You May Also Like

Related Analysis
  1. Charts & Patterns

    Avoid The Perfection Trap In Trading

  2. Investing

    Why We Need Antitrust Laws

  3. Professionals

    DCF Vs. Comparables: Which One To Use

  4. Trading Strategies

    Adjust Market Strategies To Elevated Risk

  5. Personal Finance

    How Express Scripts Makes Money

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!